These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2575719

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Experiences of long-term treatment with remoxipride: efficacy and tolerability.
    Wålinder J, Holm AC.
    Acta Psychiatr Scand Suppl; 1990; 358():158-63. PubMed ID: 1978477
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.
    Morrison D, Englund A, Lawrie V, Lewander T, Schlachet A, Westerbergh SE.
    Acta Psychiatr Scand Suppl; 1990; 358():164-9. PubMed ID: 1978478
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.
    King DJ, Blomqvist M, Cooper SJ, Doherty MM, Mitchell MJ, Montgomery RC.
    Psychopharmacology (Berl); 1992; 107(2-3):175-9. PubMed ID: 1352050
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC, Shin JG, Kelly DL, Jung DU, Seo YS, Liu KH, Shon JH, Conley RR.
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
    Kagerer S, Winter C, Möller HJ, Soyka M.
    Neuropsychobiology; 2003 Sep; 47(4):212-8. PubMed ID: 12824745
    [Abstract] [Full Text] [Related]

  • 36. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W.
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
    [Abstract] [Full Text] [Related]

  • 37. Remoxipride versus haloperidol in healthy volunteers: psychometric performance and subjective tolerance profiles.
    Rammsayer T, Gallhofer B.
    Int Clin Psychopharmacol; 1995 Mar; 10(1):31-7. PubMed ID: 7622802
    [Abstract] [Full Text] [Related]

  • 38. The treatment of negative symptoms: a clinical and methodological study.
    Lapierre YD, Angus C, Awad AG, Saxena BM, Jones B, Williamson P, Vincent P, Carle R, Lavallee YJ, Manchanda R, Gauthier B, Wolf MA, Teehan MD, Denis JF, Malla AK, Oyewumi LK, Busse E, Labelle A, Claesson L, Grafford K.
    Int Clin Psychopharmacol; 1999 Mar; 14(2):101-12. PubMed ID: 10220125
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Remoxipride in schizophrenia: effects on plasma prolactin.
    Chouinard G, Turnier L, Kallai-Sanfacon MA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 Mar; 9(5-6):599-603. PubMed ID: 2868493
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.